Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia.

To assess patient-reported efficacy and safety of ramelteon in Japanese patients with chronic insomnia.
Randomized, double-blind, placebo-controlled, multicenter trial. After a placebo lead-in period, 987 adults with chronic insomnia received ramelteon 8 mg or placebo once daily for 2 weeks, followed by a placebo run-out period to monitor rebound insomnia. Patient-reported sleep data were collected using sleep diaries.
Ramelteon significantly reduced mean patient-reported sleep latency (primary endpoint) compared with placebo during week 1 (-4.54 min; p=0.001). Ramelteon maintained greater efficacy in sleep latency than placebo at week 2, but the difference did not achieve statistical significance. In a subset of patients who adhered to treatment and completed their diaries as instructed, a statistically significant reduction in subjective sleep latency was sustained through week 2. Compared with placebo, ramelteon also significantly improved mean total sleep time and mean sleep quality during week 1, the number of awakenings during week 2, and overall patient global impression scores. There was no evidence of rebound insomnia. Adverse events were generally mild and transient.
In Japanese adults with chronic insomnia, ramelteon 8 mg significantly reduced patient-reported sleep latency, increased total sleep time and improved sleep quality after 1 week of treatment. Ramelteon was generally well tolerated with no rebound insomnia.
AuthorsMakoto Uchiyama, Misako Hamamura, Tomoaki Kuwano, Hiroshi Nishiyama, Hiroshi Nagata, Naohisa Uchimura
JournalSleep medicine (Sleep Med) Vol. 12 Issue 2 Pg. 119-26 (Feb 2011) ISSN: 1878-5506 [Electronic] Netherlands
PMID21256803 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 Elsevier B.V. All rights reserved.
Chemical References
  • Indenes
  • Placebos
  • ramelteon
  • Adult
  • Aged
  • Aged, 80 and over
  • Asian Continental Ancestry Group
  • Female
  • Humans
  • Indenes (administration & dosage, adverse effects)
  • Male
  • Medical Records
  • Middle Aged
  • Patient Satisfaction
  • Placebos
  • Secondary Prevention
  • Sleep (drug effects)
  • Sleep Initiation and Maintenance Disorders (drug therapy)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: